Table 2 Protocol for the treatment of triton induce hyperlipidemia in rats
Group | Treatment/route of administration |
|---|---|
NC | Solvent system (vehicle) |
HLC | Hyperlipidemic control |
FVT-1 | Hyperlipidemic + plant extract (FVBM) (50 mg/rat) |
FVT-2 | Hyperlipidemic + plant extract (FVBM) (100 mg/rat) |
CT | Hyperlipidemic + bioactive compound (F18) (1 mg/rat) |
AT | Hyperlipidemic + standard (atorvastatin) (1 mg/rat) |